AIDA at the Daiichi Sankyo European Oncology Patient Advocacy Forum

AIDA was featured at the Daiichi Sankyo European Oncology Patient Advocacy Forum in Munich, where Digestive Cancers Europe (DiCE) presented how the project uses artificial intelligence to support personalised gastric cancer prevention.

The forum gathered patient advocates and experts to discuss how AI can enhance oncology by:

  • Empowering patients
  • Improving early detection
  • Supporting personalised treatment decisions
  • Accelerating research

AIDA’s AI models aim to detect precancerous gastric inflammation early and translate complex data into meaningful insights for clinicians and patients.

This event highlighted the importance of patient-centred innovation and reinforced AIDA’s commitment to engaging the public, listening to patient experiences, and ensuring AI tools support real clinical needs.

Share

You might also be interested in

en

AIDA Partner LU KPMI Represents Europe at HUG 2025 in Seoul

From 20–22 March, AIDA partner LU KPMI (University of Latvia) participated in the HUG 2025 Symposium in Seoul, South Korea, one of the leading international meetings focused on Helicobacter pylori and upper gastrointestinal diseases.

en

AIDA Publishes Major AI Breakthrough in Nature Communications

AIDA researchers have published a significant scientific advance in Nature Communications: an AI-powered “Clinician” capable of recommending personalised treatment for Helicobacter pylori (H. pylori), the leading cause of gastric cancer worldwide.

en

DiCE Hosts ENTERO Policy Event at the European Parliament

On April 24th, Digestive Cancers Europe (DiCE), a partner of the AIDA consortium, organised the ENTERO Policy Event at the European Parliament. The event brought together policymakers, clinicians, researchers, and patient advocates to highlight a growing concern in Europe: the rise of early-onset digestive cancers, including colorectal and gastric cancer.